236. Pseudohypoparathyroidism Clinical trials / Disease details

Clinical trials : 6 / Drugs : 4 - (DrugBank : 2) / Drug target genes : 20 - Drug target pathways : 28

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00497484 (ClinicalTrials.gov)	February 1995	5/7/2007	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Pseudohypoparathyroidism;Growth Hormone Deficiency, Dwarfism	Drug: recombinant human somatotropin	University of Milan	Eli Lilly and Company	Active, not recruiting	1 Year	18 Years	Both		N/A	Italy

First Previous1Next Last